The rules on the processing of personal data for health research purposes have been revised with the implementation of the new Data Protection Act 2018 (Section 36(2)) (Health Research) (Amendment) Regulations 2021 (the “2021 Regulations“). The amendments introduced in the 2021 Regulations include:
- new best practice requirements for explicit consent as a suitable and specific measure to protect the rights and freedoms of individuals;
- new rules on pre-screening individuals for inclusion in health research;
- exempting retrospective chart review studies from the explicit consent requirement;
- deferring the requirement for consent where an individual is incapable of giving consent due to mental or physical incapacity;
- providing an exemption for the requirement of explicit consent as a suitable and specific measure where an individual provided valid consent under the Data Protection Directive which has not been withdrawn; and
- improvements to the appeals process.
Please click here or on the image below to download our briefing:
Recommended Insights
Article and Insights
8
Aug 2023
The Irish M&A market experienced a dip of 2% in the number of qualifying deals dur...

Partner
Stephen Keogh
Article and Insights
6
Sep 2023
Welcome to the September 2023 edition of our Asset Management & Investment Funds U...

Partner
Patricia Taylor
Article and Insights
21
Dec 2022
The Central Bank of Ireland highlights the key prudential risks that will inform i...

Partner
Eoin Caulfield
Article and Insights
27
Jan 2023
William Fry is pleased to celebrate the Council of Europe's annual Data Protection...

Senior Associate
Rachel Hayes
Article and Insights
17
Feb 2023
On 16 February 2023, the Central Bank published a Dear CEO Letter addressing the C...

Partner
Shane Kelleher
Article and Insights
18
Mar 2020

Consultant
John Larkin
Report
8
Aug 2023
In line with international deal activity, Ireland’s mergers and acquisitions (M&A)...

Partner
Stephen Keogh
prev
next